TITLE

Treating Onychomycosis

AUTHOR(S)
Rodgers, Phillip; Bassler, Mary
PUB. DATE
February 2001
SOURCE
American Family Physician;2/15/2001, Vol. 63 Issue 4, p663
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Onychomycosis accounts for one third of fungal skin infections. Because only about one half of nail dystrophies are caused by fungus, the diagnosis should be confirmed by potassium hydroxide preparation, culture or histology before treatment is started. Newer, more effective antifungal agents have made treating onychomycosis easier. Terbinafine and itraconazole are the therapeutic agents of choice. Although the U.S. Food and Drug Administration has not labeled fluconazole for the treatment of onychomycosis, early efficacy data are promising. Continuous oral terbinafine therapy is most effective against dermatophytes, which are responsible for the majority of onychomycosis cases. Intermittent pulse dosing with itraconazole is as safe and effective as short-term continuous therapy but more economical and convenient. With careful monitoring, patients treated with the newer antifungal agents have a good chance of achieving relief from onychomycosis and its complications.
ACCESSION #
4139294

 

Related Articles

  • Fungal nail dystrophy. Chittari, Kim; Ilchyshyn, Andrew // Update;Jul2007, Vol. 75 Issue 1, p21 

    The article presents information on the diagnosis and the topical and systemic antifungal therapy of nail infection. In onychomycosis, the concentration of fungus is highest in the nail bed. Sublingual debris should be collected from the most proximal and lateral portion of the affected nail bed...

  • Topical Solution for Nail Fungus. Preboth, Monica // American Family Physician;10/1/2001, Vol. 64 Issue 7, p1280 

    Reports on the approval of ciclopirox topical solution, 8 percent, for the treatment of onychomycosis by the United States Food and Drug Administration. Description of the solution and its use; Side effects.

  • Molecular Identification of Fusarium Species in Onychomycoses. Ninet, Béatrice; Jan, Isabelle; Bontems, Olympia; Léchenne, Barbara; Jousson, Olivier; Lew, Daniel; Schrenzel, Jacques; Panizzon, Renato G.; Monod, Michel // Dermatology (10188665);2005, Vol. 210 Issue 1, p21 

    Background:Fusarium species are isolated from about 3% of onychomycoses in the Swiss native population. On the basis of macroscopic characters and microscopic examination of the cultures, identification of Fusarium often remains difficult or uncertain because of variations from one isolate to...

  • White superficial onychomycosis.  // Journal of Cutaneous Medicine & Surgery;Sep/Oct2004, Vol. 8 Issue 5, p380 

    Discusses the abstract of the study "White Superficial Onychomycosis," by B.M. Piraccini and colleagues.

  • Onychomycosis Alternative. Hill, Suzette // Dermatology Times;May2003, Vol. 24 Issue 5, p20 

    Focuses on the use of clotrimazole lacquer formulated with the drug delivery technology CPE-215 for treating onychomycosis. Improvement of patients using clotrimazole lacquer.

  • Study of onychomycosis. Vijaya, D.; Anandkumar, B.H.; Geetha, S.H. // Indian Journal of Dermatology, Venereology & Leprology;May/Jun2004, Vol. 70 Issue 3, p185 

    Cites key findings from several microbiology and dermatology experts' microbiological study of onychomycosis.

  • Onychodystrophy as the only sign of congenital candidiasis. Joy Way Bueno, Susy M.; Santos Muñoz, Andrea; Maldonado, Ivana; Larralde, Margarita // Pediatric Dermatology;Jan2020, Vol. 37 Issue 1, p159 

    Congenital candidiasis infection often presents as a skin rash with variable involvement of nails and mucous membranes. Isolated nail involvement is rare, may present late, and can often be managed with topical antifungal medication. We report a case of congenital candidiasis limited to the...

  • Search for biological control agents against Candida yeasts and other dermatomycetes. Melvydas, V.; Šakalytė, J.; Paškevičius, A.; Gedminienė, G. // Biologija;2007, Issue 1, p45 

    The objective of this work was to screen the killer action of the bacterial isolates T1x, T2x, T3x, Ux and Ux308 against some dermatomycetes and the genus Candida yeast. The bacterial isolates T1x, T2x, T3x, Ux were recovered from spontaneous fruit and berry fermentations and the Ux308 isolate...

  • Onychomycosis in two geographically distinct regions in India. Gurung, Shrijana; Yegneshwaran, Prakash Peralam; Bhutia, Pema Yoden; Gupta, Amlan; Bairy, Indira; Pradhan, Jagat; Pradhan, Uttam; Sharma, Dhruva; Peggy, Tshering // Archives of Clinical Microbiology;2012, Vol. 3 Issue 6, p1 

    Background: Onychomycosis is worldwide in distribution and the genera of causative agents are diverse. This study was carried out to demonstrate if the causative agents differed with a difference in temperature, climate and locale. Methods: Seventy patients in coastal tropical region of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics